Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 7
Submit an article Journal homepage
79
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Differential Expression of Human Equilibrative Nucleoside Transporter 1 (hENT1) Protein in the Reed-Sternberg Cells of Hodgkin's Disease

Tony Reiman Department of Medicine, Cross Cancer Institute, Edmonton, Albta., Canada, T6G 1Z2
,
Marilyn L. Clarke Department of Experimental Oncology, Cross Cancer Institute, Edmonton, Albta., Canada, T6G 1Z2
,
Laith Dabbagh Department of Pathology, Cross Cancer Institute, Edmonton, Albta., Canada, T6G 1Z2
,
Michaela Vsianska Masaryk Memorial Cancer Institute, Brno, Czech Republic
,
Robert W. Coupland Department of Biochemistry, University of Alberta, Edmonton, Albta., Canada, T6G 1Z2
,
Andrew R. Belch Department of Oncology, University of Alberta, Edmonton, Albta., Canada, T6G 1Z2
,
Stephen A. Baldwin School of Biochemistry and Molecular Biology, University of Leeds, Leeds, UK
,
James D. Young Department of Physiology, University of Alberta, Edmonton, Albta., Canada, T6G 1Z2
,
Carol E. Cass Department of Experimental Oncology, Cross Cancer Institute, Edmonton, Albta., Canada, T6G 1Z2
&
John R. Mackey Department of Pathology, Cross Cancer Institute, Edmonton, Albta., Canada, T6G 1Z2
 show all
Pages 1435-1440 | Published online: 01 Jul 2009

  • Zinzani, P.L., et al., (2000) "Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patients", Haematologica 85 (9), 926 - 929
  • Santoro, A., et al., (2000) "Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study", J. Clin. Oncol. 18 (13), 2615 - 2619
  • Abbruzzese, J.L. (1996) "Phase I studies with the novel nucleoside analog gemcitabine", Semin. Oncol. 23 (5 Suppl. 10), 25 - 31
  • Plunkett, W., et al., (1995) "Gemcitabine: metabolism, mechanisms of action, and self-potentiation", Semin. Oncol. 22 (4 Suppl. 11), 3 - 10
  • A.P. Association, Solimando, D.A., et al. (1999) Drug Information Handbook for Oncology (Lexi-Comp, Hudson, Cleveland, OH)
  • Vickers, M.F., et al., (2000) "Nucleoside transporter proteins: emerging targets for drug discovery", Emerg. Ther. Targets 4 (4), 515 - 539
  • Cass, C.E., et al., (1999) "Nucleoside transporters of mammalian cells", Pharm. Biotechnol. 12, 313 - 352
  • Baldwin, S.A., et al., (1999) "Nucleoside transporters: molecular biology and implications for therapeutic development", Mol. Med. Today 5 (5), 216 - 224
  • Mackey, J.R., et al., (1998) "The role of nucleoside transport in anticancer drug resistance", Drug Resist. Updates 1 (5), 310 - 324
  • Mackey, J.R., et al., (1998) "Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines", Cancer Res. 58, 4349 - 4357
  • Janowska-Wieczorek, A., et al., (1999) "Gemcitabine membrane transport capabilities of normal human hematopoietic progenitor (CD34+) cells", Blood 94 (10), 279a
  • Mackey, J.R., et al., (2002) "Immunohistochemical variation of human equilibrative nucleoside transporter 1 (hENT1) protein in primary breast cancers", Clin. Cancer Res., 8, 110 - 116
  • Cass, C.E., Muzik, H. and Paterson, A.R. (1975) "Combination therapy of mouse leukemia L1210 by 1-beta- d -arabinofuranosylcytosine and 6-[(4-nitrobenzyl)thio]-9-beta- d -ribofuranosylpurine", Cancer Res. 35 (5), 1187 - 1193
  • Cass, C.E., et al., (1981) "Absence of binding sites for the transport inhibitor nitrobenzylthioinosine on nucleoside transport-deficient mouse lymphoma cells", Biochim. Biophys. Acta 649 (3), 769 - 777
  • Cass, C.E., et al., (1992) "A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin)", Cancer Res. 52 (21), 5879 - 5886
  • Paterson, A.R., et al., (1979) "Low specificity of the nucleoside transport mechanism of RPMI 6410 cells", Mol. Pharmacol. 16 (3), 900 - 908
  • Wiley, J.S., Jones, S.P. and Sawyer, W.H. (1983) "Cytosine arabinoside transport by human leukaemic cells", Eur. J. Cancer Clin. Oncol. 19 (8), 1067 - 1074
  • Wiley, J.S., et al., (1982) "Cytosine arabinoside influx and nucleoside transport sites in acute leukemia", J. Clin. Invest. 69 (2), 479 - 489
  • Gati, W.P., et al., (1998) "Es nucleoside transporter content of acute leukemia cells: role in cell sensitivity to cytarabine (arac)", Leuk. Lymph. 32, 45 - 54
  • Gati, W.P., et al., (1997) "Sensitivity of acute leukemia cells to cytarabine is a correlate of cellular es nucleoside transporter site content measured by flow cytometry with SAENTA-fluorescein", Blood 90 (1), 346 - 353
  • Wiley, J.S., et al., (1985) "Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma", J. Clin. Invest. 75 (2), 632 - 642
  • Jennings, L.L., et al., (2001) "Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system", Neuropharmacology 40, 722 - 731
  • Lister, T.A., et al., (1989) "Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting", J. Clin. Oncol. 7 (11), 1630 - 1636
  • Murray, P.G., et al., (1999) "Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease", Blood 94 (2), 442 - 447
  • Jarrett, A.F., Armstrong, A.A. and Alexander, E. (1996) "Epidemiology of EBV and Hodgkin's lymphoma", Ann. Oncol. 7 (Suppl. 4), 5 - 10
  • Santoro, A., et al., (1997) "Phase II study with gemcitabine in pretreated patients with Hodgkin's (HD) and non-Hodgkin's lymphomas (NHL): results of a multicenter study", Proc. Annu. Meet. Am. Soc. Clin. Oncol. 16, A71
  • Hanel, M., et al., (2001) "Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma", J. Cancer Res. Clin. Oncol. 127 (6), 387 - 395
  • Betticher, D.C., et al., (1994) "High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias", Ann. Oncol. 5 (1), 57 - 64
  • Cummings, F.J., et al., (1991) "Phase II trial of pentostatin in refractory lymphomas and cutaneous T-cell disease", J. Clin. Oncol. 9 (4), 565 - 571
  • Martin, A., et al., (2001) "Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease", Br. J. Haematol. 113 (1), 161 - 171
  • Diehl, V., Mauch, P.M. and Harris, N.L. (2000) "Hodgkin's disease. Chapter 45.6", In: DeVita, V.T., Hellmann, S. and Rosenberg, S.A., eds, Cancer: Principles and Practice of Oncology (Lippincott Williams and Wilkins, Philadelphia, PA), pp 2339 - 2387
  • Thomas, J., et al., (1992) "Phase II study of cytarabine in Hodgkin's disease. The EORTC Lymphoma Cooperative Group", Eur. J. Cancer, 857 - 859
  • Wiley, J.S., Smith, C.L. and Jamieson, G.P. (1991) "Transport of 2′-deoxycoformycin in human leukemic and lymphoma cells", Biochem. Pharmacol. 42 (3), 708 - 710
  • Kaplinsky, C., et al., (1986) "Selective protection of tubercidin toxicity by nitrobenzyl thioinosine in normal tissues but not in human neuroblastoma cells", Cancer Chemother. Pharmacol. 17 (3), 264 - 268
  • Boumah, C.E., Hogue, D.L. and Cass, C.E. (1992) "Expression of high levels of nitrobenzylthioinosine-sensitive nucleoside transport in cultured human choriocarcinoma (BeWo) cells", Biochem. J. 288 (Pt 3), 987 - 996
  • Pressacco, J., et al., (1995) "Modulation of the equilibrative nucleoside transporter by inhibitors of DNA synthesis", Br. J. Cancer 72 (4), 939 - 942
  • Cass, C.E., et al., (1979) "Fluctuations in nucleoside uptake and binding of the inhibitor of nucleoside transport, nitrobenzylthioinosine, during the replication cycle of HeLa cells", Cancer Res. 39 (4), 1245 - 1252
  • Wiley, J.S., et al., (1994) "Assessment of proliferative responses to granulocyte-macrophage colony-stimulating factor (GM-CSF) in acute myeloid leukaemia using a fluorescent ligand for the nucleoside transporter", Leukemia 8 (1), 181 - 185
  • Smith, C.L., et al., (1989) "Nucleoside transport and proliferative rate in human thymocytes and lymphocytes", Blood 74 (6), 2038 - 2042
  • Goh, L.B., Mack, P. and Lee, C.W. (1995) "Nitrobenzylthioinosine-binding protein overexpression in human breast, liver, stomach and colorectal tumour tissues", Anticancer Res. 15 (6B), 2575 - 2579
  • Fung, M.C., et al., (1999) "A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy", Cancer 85 (9), 2023 - 2032
  • Dumontet, C., et al., (2001) "Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma", Br. J. Haematol. 113 (3), 772 - 778
  • Pavlakis, N., et al., (1997) "Fatal pulmonary toxicity resulting from treatment with gemcitabine", Cancer 80 (2), 286 - 291
  • Gietema, J.A., et al., (1998) "Effects of gemcitabine on renal function in patients with non-small cell lung cancer", Eur. J. Cancer 34 (1), 199 - 202
  • Fracasso, P.M., et al., (1999) "Membranoproliferative glomerulonephritis following gemcitabine and vinorelbine chemotherapy for peritoneal mesothelioma", J. Natl Cancer Inst. 91 (20), 1779 - 1780
  • Bruns, C.J., et al., (2000) "Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms", Clin. Cancer Res. 6 (5), 1936 - 1948
  • Trumper, L.H., et al., (1993) "Single-cell analysis of Hodgkin and Reed-Sternberg cells: molecular heterogeneity of gene expression and p53 mutations", Blood 81 (11), 3097 - 3115
  • Kuppers, R., et al., (1994) "Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development", Proc. Natl Acad. Sci. USA 91 (23), 10962 - 10966
  • Kanzler, H., et al., (1996) "Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells", J. Exp. Med. 184 (4), 1495 - 1505
  • Jox, A., et al., (1998) "Detection of identical Hodgkin-Reed-Sternberg cell specific immunoglobulin gene rearrangements in a patient with Hodgkin's disease of mixed cellularity subtype at primary diagnosis and in relapse two and a half years later", Ann. Oncol. 9 (3), 283 - 287
  • Hasenclever, D. and Diehl, V. (1998) "A prognostic score for advanced Hodgkin's disease. International prognostic factors project on advanced Hodgkin's disease", N. Engl. J. Med. 339 (21), 1506 - 1514

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.